Journal article

Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010


Authors listGhofrani, H. A.; Distler, O.; Gerhardt, F.; Gorenflo, M.; Gruenig, E.; Haefell, W. E.; Held, M.; Hoeper, M. M.; Kaehler, C.-M.; Kaemmerer, H.; Klose, H.; Koellner, V.; Kopp, B.; Mebus, S.; Meyer, A.; Miera, O.; Pittrow, D.; Riemekasten, G.; Rosenkranz, S.; Schranz, D.; Voswinckel, R.; Olschewski, H.

Publication year2010

PagesS87-S101

JournalDeutsche Medizinische Wochenschrift

Volume number135

ISSN0012-0472

eISSN1439-4413

DOI Linkhttps://doi.org/10.1055/s-0030-1263316

PublisherGeorg Thieme Verlag



Citation Styles

Harvard Citation styleGhofrani, H., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W., et al. (2010) Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010, Deutsche Medizinische Wochenschrift, 135, pp. S87-S101. https://doi.org/10.1055/s-0030-1263316

APA Citation styleGhofrani, H., Distler, O., Gerhardt, F., Gorenflo, M., Gruenig, E., Haefell, W., Held, M., Hoeper, M., Kaehler, C., Kaemmerer, H., Klose, H., Koellner, V., Kopp, B., Mebus, S., Meyer, A., Miera, O., Pittrow, D., Riemekasten, G., Rosenkranz, S., ...Olschewski, H. (2010). Treatment of pulmonary arterial hypertension (PAH): Recommendations of the Cologne Consensus Conference 2010. Deutsche Medizinische Wochenschrift. 135, S87-S101. https://doi.org/10.1055/s-0030-1263316



Keywords


BOSENTAN THERAPYCONTROLLED-TRIALDOUBLE-BLINDEISENMENGER-SYNDROMEEndothelin receptor antagonistsEPOPROSTENOL THERAPYINHALED ILOPROSTPhosphodiesterase type 5 inhibitorsPORTOPULMONARY HYPERTENSIONprostanoidspulmonary arterial hypertension (PAH)SILDENAFILTREPROSTINIL

Last updated on 2025-21-05 at 18:42